These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23376188)

  • 21. Some insights into mechanism for binding and drug resistance of wild type and I50V V82A and I84V mutations in HIV-1 protease with GRL-98065 inhibitor from molecular dynamic simulations.
    Hu GD; Zhu T; Zhang SL; Wang D; Zhang QG
    Eur J Med Chem; 2010 Jan; 45(1):227-35. PubMed ID: 19910081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease.
    Dewdney TG; Wang Y; Liu Z; Sharma SK; Reiter SJ; Brunzelle JS; Kovari IA; Woster PM; Kovari LC
    Bioorg Med Chem; 2013 Dec; 21(23):7430-4. PubMed ID: 24128815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of action of aspartic proteinases. 2. Conformational possibilities of an HIV-1 proteinase substrate].
    Popov ME; Kashparov IV; Popov EM
    Bioorg Khim; 1996 Jul; 22(7):510-22. PubMed ID: 8992956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations.
    Piana S; Carloni P; Rothlisberger U
    Protein Sci; 2002 Oct; 11(10):2393-402. PubMed ID: 12237461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.
    Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J
    J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of action of aspartic proteinases. V. Conformational characteristics of fragments of substrate-binding sites in rhizopuspepsin and HIV-1 proteinase].
    Kashparov IV; Popov ME; Rumsh LD; Popov EM
    Bioorg Khim; 1999 Aug; 25(8):597-602. PubMed ID: 10578465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of discordant HIV-1 protease resistance rankings using molecular dynamics simulations.
    Wright DW; Coveney PV
    J Chem Inf Model; 2011 Oct; 51(10):2636-49. PubMed ID: 21902276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation.
    Liu F; Kovalevsky AY; Louis JM; Boross PI; Wang YF; Harrison RW; Weber IT
    J Mol Biol; 2006 May; 358(5):1191-9. PubMed ID: 16569415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
    Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
    Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catalytic water co-existing with a product peptide in the active site of HIV-1 protease revealed by X-ray structure analysis.
    Prashar V; Bihani S; Das A; Ferrer JL; Hosur M
    PLoS One; 2009 Nov; 4(11):e7860. PubMed ID: 19924250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamical Network of HIV-1 Protease Mutants Reveals the Mechanism of Drug Resistance and Unhindered Activity.
    Appadurai R; Senapati S
    Biochemistry; 2016 Mar; 55(10):1529-40. PubMed ID: 26892689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S.
    Bihani SC; Das A; Prashar V; Ferrer JL; Hosur MV
    Biochem Biophys Res Commun; 2009 Nov; 389(2):295-300. PubMed ID: 19720046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.
    Ohtaka H; Schön A; Freire E
    Biochemistry; 2003 Nov; 42(46):13659-66. PubMed ID: 14622012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational sampling.
    Carter JD; Gonzales EG; Huang X; Smith AN; de Vera IM; D'Amore PW; Rocca JR; Goodenow MM; Dunn BM; Fanucci GE
    FEBS Lett; 2014 Aug; 588(17):3123-8. PubMed ID: 24983495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.
    Wittayanarakul K; Aruksakunwong O; Sompornpisut P; Sanghiran-Lee V; Parasuk V; Pinitglang S; Hannongbua S
    J Chem Inf Model; 2005; 45(2):300-8. PubMed ID: 15807491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HIV type 1 protease L10I minor mutation decreases replication capacity and confers resistance to protease inhibitors.
    Flor-Parra F; Pérez-Pulido AJ; Pachón J; Pérez-Romero P
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):65-70. PubMed ID: 21142921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving Mutational Buildup in HIV-1 Protease Shifts Conformational Dynamics to Gain Drug Resistance.
    Souffrant M; Yao XQ; Hamelberg D
    J Chem Inf Model; 2023 Jun; 63(12):3892-3902. PubMed ID: 37285207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle.
    Karthik S; Senapati S
    Proteins; 2011 Jun; 79(6):1830-40. PubMed ID: 21465560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases.
    Ode H; Ota M; Neya S; Hata M; Sugiura W; Hoshino T
    J Phys Chem B; 2005 Jan; 109(1):565-74. PubMed ID: 16851048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.